Reliance Life Sciences is building an integrated and global biosimilars business.

The company currently markets biosimilars in India and overseas markets.

These products are manufactured in-house in two commercial scale facilities for recombinant proteins and monoclonal antibodies (mammalian and microbial cell culture and fill finish for vials and syringes).